PRKCB

PRKCB Full Name

protein kinase C, beta

PRKCB Introduction

Protein Kinase C Beta (PRKCB) is a key member of the Protein Kinase C (PKC) family, functioning as a serine/threonine-specific protein kinase that plays a central regulatory role in cellular signaling networks. Its activation depends on calcium ions and phospholipids such as diacylglycerol (DAG), positioning it as an important effector in intracellular second messenger pathways. The PRKCB gene encodes this enzyme and undergoes alternative splicing to produce at least two major protein isoforms: PRKCB1 and PRKCB2. These isoforms differ in tissue distribution and specific cellular functions, enabling fine-tuned regulation of biological processes. As a typical protein kinase, PRKCB modulates a wide range of cellular activities—including proliferation, apoptosis, differentiation, and gene expression—by phosphorylating specific serine or threonine residues on its target proteins, thereby altering their activity, localization, or stability.

Figure 1. Schematic of the domain structure of the mammalian PKCβ isoform. (Source: Mehta NK, et al. 2014)

PRKCB plays essential roles in various physiological processes, particularly in immune function and metabolic regulation. In the immune system, it acts as a critical node in the B-cell receptor (BCR) signaling pathway. Upon antigen-induced BCR activation, PRKCB is recruited and activated, leading to phosphorylation of downstream substrates and ultimately triggering activation of the transcription factor NF-κB. This pathway is vital for B-cell survival, proliferation, differentiation, and antibody production. Beyond immunity, PRKCB is involved in insulin signaling and endothelial cell proliferation. It also influences cellular metabolic states—for example, in B cells, it regulates mitochondrial remodeling and metabolic reprogramming to meet energy demands following activation.

Due to its broad role in signal transduction, dysregulation of PRKCB is closely linked to several human diseases. In metabolic disorders, PRKCB is considered a key player in type 2 diabetes (T2DM) and its complications. Under hyperglycemic conditions, PRKCB becomes overactivated, contributing to insulin resistance and pancreatic β-cell dysfunction. Notably, its activation is a critical pathological mechanism in microvascular complications such as diabetic retinopathy and nephropathy, driving vascular endothelial dysfunction, inflammation, and increased vascular permeability.

Alternate Names for PRKCB

PRKCB; protein kinase C, beta; Pkcb; Prkcb1; Prkcb2; PKC-Beta; A130082F03Rik; protein kinase C beta type; PKC-B; protein kinase C beta-II; protein kinase C, beta 1;

• 1. Mehta NK, et al. Protein kinase C-beta: An emerging connection between nutrient excess and obesity. Biochim Biophys Acta. 2014 Oct;1841(10):1491-1497.
  2. Kawakami T, et al. Protein kinase C beta (PKC beta): normal functions and diseases. J Biochem. 2002 Nov;132(5):677-82.